Heparin should not be used presently for acute ischaemic stroke

Journal of Clinical Neuroscience

Volumn 7, Issue 2, 2000, Pages 160-161

  Hankey, G J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR;

ANTICOAGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAPILLARY RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION PAIN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; STROKE;

EID: 0033942559     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0216     Document Type: Short Survey

References (8)

1. E.E Marsh III H.P Adams Jr J Biller Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States Neurology 29 1989 1631 1634
2. M.A Smith E Shahar K.M Doliszny P.G McGovern D.K Arnett R.V Luepker Trends in medical care of hospitalised stroke patients between 1980 and 1990: The Minnesota Stroke Survey J Stroke and Cerebrovascular Diseases 7 1998 76 84
3. R.I Lindley E.O Amayo J Marshall Acute stroke treatment in UK hospitals: The Stroke Association Survey of consultant opinion J R Coll Physicians Lond 29 1995 479 484
4. D.L Sackett Rules of evidence and clinical recommendations on the use of antithrombotic agents Chest 95 (2) 1989 2S 4S
5. P.A.G Sandercock G Gubitz C Counsell D Signorini Immediate anticoagulant therapy for acute ischaemic stroke. Part 1: A systematic review of 21 randomised-trials of anticoagulant vs control, including 23 374 patients. (abstract) Stroke 30 1999 248
6. JAMA 279 1998 1265 1272
7. G.J Hankey Heparin in acute ischaemic stroke. The T wave is negative and its time to stop MJA 169 1998 534 536
8. G.J Hankey Heparin in acute ischaemic stroke MJA 170 1999 567 568